Alvarez & Marsal expanded its healthcare industry group with the appointments of senior directors Anna Kuang, M.D.; Jonathan Masoudi, M.D.; and Rebecca Palm, who are based in Los Angeles, Denver and Boston, respectively.
The addition of these professionals adds a range of expertise and experience to build upon Alvarez & Marsal’s offerings across the healthcare industry, specifically across pharmaceutical and biotechnology, healthcare providers and healthcare services and life sciences organizations.
“The pandemic has extraordinarily challenged the healthcare industry. During these unprecedented times, Alvarez and Marsal’s healthcare industry group has continued to support clients across all points of the healthcare delivery continuum,” Peter Urbanowicz, managing director and co-head of Alvarez & Marsal’s healthcare industry group, said. “To continue to meet market needs, we have added experienced, accomplished, clinical, senior-level talent who are equipped to help healthcare organizations navigate this uncertain future.”
“Dr. Kuang, Dr. Masoudi and Ms. Palm bring decades of frontline industry and operational experience,” Martin McGahan, managing director and co-head of Alvarez & Marsal’s healthcare industry group, said. “With Drs. Kuang and Masoudi’s clinical background and Ms. Palm’s ability to drive performance improvement, these three professionals bring a whole new level of impact and value for healthcare organizations.”
Kuang has more than 25 years of experience as an industry executive and clinician driving innovation and commercialization for biotech and medtech companies from early stage to large corporations. She specializes in developing strategic growth opportunities, risk mitigation, competitive positioning and performance efficiencies by identifying and navigating pathways for commercial success that align with clinical and customer needs. She also has experience with initiatives that have included M&A, due diligence, the supply chain, regulatory strategy, clinical trials and go-to-market strategies.
Prior to joining Alvarez & Marsal, Kuang served as vice president of precision medicine for Emulate Bio and as founder and CEO of Patchmi, where she also led intellectual property and regulatory strategy for medical device development. Kuang is an actively practicing and board-certified plastic and reconstructive surgeon with a background in immunology research.
Masoudi is a board-certified urologist and healthcare executive who served Kaiser Permanente of Colorado (KPCO) as an area medical director and vice president of operations.
At KPCO, during the largest regional financial turnaround in the company’s history, Masoudi led specialty care operations throughout the first year of the pandemic, working with the emergency operations center to stop face-to face operations and transition to virtual care before reopening safely. Additionally, Masoudi led the shift of outpatient surgeries from a hospital to an ambulatory surgical venue, resulting in $23 million in cost savings in the first year.
Palm has more than 25 years of experience building and leading financial services and healthcare organizations, with expertise in new product and services development. Palm joined Alvarez & Marsal from Steward Health Care, an international integrated delivery system where, as the chief administrative officer, she established a scalable management service organization that supported 300% growth in network size over a six-month period.
Palm’s experience includes building new revenue cycle, electronic medical record and patient engagement product lines. She has also led product strategy, build-vs.-buy decisions and strategic acquisitions, including transactions for data analytics, care coordination and population health management companies. Palm has worked with healthcare delivery organizations, accountable care organizations, venture-backed startups and healthcare technology providers.
